Restrictions on Psilocybin 'Magic Mushrooms' Are Easing as Research Ramps Up

Sponsored by

Trouble viewing? View in your browser. View all Scientific American publications.

    

January 04, 2023

Policy Restrictions on Psilocybin 'Magic Mushrooms' Are Easing as Research Ramps Up Here's how the psychedelic substance's legal status has been shifting By Simon Makin

Animals Predators Act like Butterflies' Eyespots Are Looking Right at Them Butterfly markings work better when they're "looking" toward prey By Maddie Bender

Public Health Masks Are a Proved Way to Defend Yourself from Respiratory Infections Respiratory viruses have rebounded hard after COVID seclusion, and masks are one of the best ways to avoid getting them By Emily Toth Martin,Marisa Eisenberg,The Conversation US

Sponsor Content Provided by KAUST Fully-funded Internship Opportunities at KAUST Gain hands on experience and training in KAUSTs world-class research facilities while being mentored by renowned researchers. Over 100 real-world projects are currently available across 16 STEM disciplines. Find out more today at the VSRP website.

Paleontology Tiny Tyrannosaurs Used the Buddy System Fossil trackways may show tyrannosaur tykes teaming up By Riley Black

Ecology Rare Animals' Microbiomes Harbor Survival Secrets Scientists are beginning to decode endangered creatures' microbial ecosystems By Kate Evans

Artificial Intelligence ChatGPT Explains Why AIs like ChatGPT Should Be Regulated We asked the text-generating AI ChatGPT to talk about its own flaws By Sophie Bushwick,Madhusree Mukerjee

Public Health Editors' Picks: Our Favorite Opinions of 2022 Our opinion section took us to the front lines of COVID, revealed how racists misuse evolutionary biology, illuminated a mental health epidemic in kids, and more By Megha Satyanarayana

Conservation Saving Coral Reefs with Dental Tech Dental scanners could help researchers diagnose stressed-out baby corals By Susan Cosier

FROM THE STORE Scientific American Volume 328, Issue 1

FROM THE ARCHIVE A Psychedelic May Soon Go to the FDA for Approval to Treat Trauma MDMA, known as Ecstasy in the clubs, gained high marks in a clinical trial for PTSD By Jennifer M. Mitchell | February 2022

QUOTE OF THE DAY "It's inconceivable the WHO could now say psilocybin doesn't have medical value. It can work where other drugs have not." David Nutt, neuropsychopharmacologist at Imperial College London

WHAT WE'RE READING Alaska's Arctic Waterways Are Turning a Foreboding Orange The phenomenon threatens local drinking water, and scientists think climate change may be the culprit. By Emily Schwing | Wired | Dec. 31, 2022

LATEST ISSUES

Questions?   Comments?

Download the Scientific American App

To view this email as a web page, go here. You received this email because you opted-in to receive email from Scientific American. To ensure delivery please add news@email.scientificamerican.com to your address book. Unsubscribe     Manage Email Preferences     Privacy Policy     Contact Us